StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) stock

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3062% above fair value
$105.43−1.68 (-1.57%)

Close on Nov 17, 2026Market cap $60.77BP/E 60.6Yield –

Edwards Lifesciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Edwards Lifesciences's pe ratio was 60.8× on Nov 11, 2026, against 37.4× a year earlier. Over the last 5 years it ranged from 10.3× to 60.8×, with a median of 35.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202660.8×+24.1
2025Dec 31, 202536.7×+26.1
2024Dec 31, 202410.7×−21.9
2023Dec 29, 202332.6×+0.4
2022Dec 30, 202232.2×−23.0
2021Dec 31, 202155.1×−17.9
2020Dec 31, 202073.0×+8.7
2019Dec 31, 201964.3×+18.3
2018Dec 31, 201846.0×+13.2
2017Dec 29, 201732.8×−4.3
2016Dec 30, 201637.0×−0.4
2015Dec 31, 201537.4×+19.8
2014Dec 31, 201417.6×−1.1
2013Dec 31, 201318.8×−21.6
2012Dec 31, 201240.4×+4.7
2011Dec 30, 201135.7×−12.4
2010Dec 31, 201048.1×+8.6
2009Dec 31, 200939.5×–

More Edwards Lifesciences figures

See a number that looks wrong?